BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25091827)

  • 1. Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer.
    Chiappa V; Di Legge A; Valentini AL; Gui B; Miccò M; Ludovisi M; Giansiracusa C; Testa AC; Valentin L
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):459-69. PubMed ID: 25091827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Transvaginal Sonography and Magnetic Resonance Imaging for Local Staging of Cervical Cancer: An Agreement Study.
    Arribas S; Alcázar JL; Arraiza M; Benito A; Minguez JA; Jurado M
    J Ultrasound Med; 2016 May; 35(5):867-73. PubMed ID: 27022170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.
    Perniola G; Fischetti M; Tomao F; Di Donato V; Palaia I; Santangelo G; Lecce F; Piccioni MG; Muzii L; Benedetti Panici P
    Oncology; 2020; 98(9):603-611. PubMed ID: 32492692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer.
    Pálsdóttir K; Fridsten S; Blomqvist L; Alagic Z; Fischerova D; Gaurilcikas A; Hasselrot K; Jäderling F; Testa AC; Sundin A; Epstein E
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):773-779. PubMed ID: 33915001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of elastography based on transvaginal ultrasound and MRI in assessing parametrial invasion of cervical cancer.
    Ma X; Li Q; Wang JL; Shao J; Zhu YC; Ding W; Zhang HS; Wang HY; Shen JK
    Clin Hemorheol Microcirc; 2017; 66(1):27-35. PubMed ID: 28211804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial.
    Epstein E; Testa A; Gaurilcikas A; Di Legge A; Ameye L; Atstupenaite V; Valentini AL; Gui B; Wallengren NO; Pudaric S; Cizauskas A; Måsbäck A; Zannoni GF; Kannisto P; Zikan M; Pinkavova I; Burgetova A; Dundr P; Nemejcova K; Cibula D; Fischerova D
    Gynecol Oncol; 2013 Mar; 128(3):449-53. PubMed ID: 23022593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of lymph node metastasis and deep stromal invasion in women with invasive cervical cancer: prospective multicenter study using 2D and 3D ultrasound.
    Pálsdóttir K; Fischerova D; Franchi D; Testa A; Di Legge A; Epstein E
    Ultrasound Obstet Gynecol; 2015 Apr; 45(4):470-5. PubMed ID: 25092154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion imaging of ultrasound and MRI in the assessment of locally advanced cervical cancer: a prospective study.
    Moro F; Gui B; Arciuolo D; Bertoldo V; Borzi R; Romeo P; Petta F; Cambi F; Pasciuto T; Zannoni GF; Valentini V; Manfredi R; Scambia G; Testa AC
    Int J Gynecol Cancer; 2020 Apr; 30(4):456-465. PubMed ID: 32193220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer.
    Testa AC; Ludovisi M; Manfredi R; Zannoni G; Gui B; Basso D; Di Legge A; Licameli A; Di Bidino R; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):335-44. PubMed ID: 19705403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The negative predictive value of clinical examination with or without anesthesia versus magnetic resonance imaging for parametrial infiltration in cervical cancer stages IB1 to IIA.
    Bleker SM; Bipat S; Spijkerboer AM; van der Velden J; Stoker J; Kenter GG
    Int J Gynecol Cancer; 2013 Jan; 23(1):193-8. PubMed ID: 23221736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional ultrasound and magnetic resonance imaging assessment of cervix and vagina in women with uterine malformations.
    Bermejo C; Martínez-Ten P; Recio M; Ruiz-López L; Díaz D; Illescas T
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):336-45. PubMed ID: 23754235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional transvaginal sonography in local staging of cervical carcinoma: description of a novel technique and preliminary results.
    Ghi T; Giunchi S; Kuleva M; Santini D; Savelli L; Formelli G; Casadio P; Costa S; Meriggiola MC; Pelusi G
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):778-82. PubMed ID: 17899576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison Between 360° 3-D Transvaginal Ultrasound and Magnetic Resonance Imaging for Assessment of Vaginal Invasion in Cervical Cancer: A Preliminary Report.
    Zhu Y; Lu M; Dai KJ; Liu C; He R
    Ultrasound Med Biol; 2021 Aug; 47(8):2250-2257. PubMed ID: 34020846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myometrial invasion in endometrial cancer using three-dimensional ultrasound and magnetic resonance imaging.
    Christensen JW; Dueholm M; Hansen ES; Marinovskij E; Lundorf E; Ørtoft G
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):55-64. PubMed ID: 26485119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional transvaginal ultrasonography for locally advanced cervical cancer.
    Byun JM; Kim YN; Jeong DH; Kim KT; Sung MS; Lee KB
    Int J Gynecol Cancer; 2013 Oct; 23(8):1459-64. PubMed ID: 24257560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver agreement and prognostic impact for MRI-based 2018 FIGO staging parameters in uterine cervical cancer.
    Wagner-Larsen KS; Lura N; Salvesen Ø; Halle MK; Forsse D; Trovik J; Smit N; Krakstad C; Haldorsen IS
    Eur Radiol; 2022 Sep; 32(9):6444-6455. PubMed ID: 35332408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-Dimensional Isotropic MRI of the Cervical Spine: A Diagnostic Comparison With Conventional MRI.
    Fu MC; Buerba RA; Neway WE; Brown JE; Trivedi M; Lischuk AW; Haims AH; Grauer JN
    Clin Spine Surg; 2016 Mar; 29(2):66-71. PubMed ID: 26889989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathological and immunohistochemical (cytokeratins AE1/AE3) study of the parametrium of patients with early stage cervical cancer.
    Cândido EB; Silva-Filho AL; Triginelli SA; Pedrosa MS; Macarenco R; Porto L; Traiman P
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):58-63. PubMed ID: 18938023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-stage cervical cancer: agreement between ultrasound and histopathological findings with regard to tumor size and extent of local disease.
    Gaurilcikas A; Vaitkiene D; Cizauskas A; Inciura A; Svedas E; Maciuleviciene R; Di Legge A; Ferrandina G; Testa AC; Valentin L
    Ultrasound Obstet Gynecol; 2011 Dec; 38(6):707-15. PubMed ID: 21538643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE).
    Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.